NASRATULLAH WAHIDI: Open Payments
NPI 1407264203 · WOODLAND, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$185 in 4 payments from 4 companies in 2025. Trend: 2023 $645 · 2024 $196 · 2025 $185
Food & beverage: $185
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 1 | $117 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
Products named: UZEDY, ABILIFY ASIMTUFII, ABILIFY MAINTENA, INVEGA SUSTENNA.
Industry payments across CA — which companies pay providers there.
